Cite
HARVARD Citation
Abrams, S. et al. (2022). Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53. Advances in biological regulation. p. . [Online].